Osama Hamdy, MD, PhD

Default Biography Avatar
Associate Professor of Medicine, Harvard Medical School, Boston, MA

Osama Hamdy, MD, PhD, FACE is a senior endocrinologist, clinical investigator and Medical Director of the Obesity Clinical Program and Director of the Inpatient Diabetes Program at Joslin Diabetes Center in Boston and Associate Professor of Medicine at Harvard Medical School. Dr. Hamdy research led to the first discovery that 7% weight loss in obese patients with and without diabetes significantly improve vascular endothelial function, insulin sensitivity and markers of inflammation. This improvement may eventually prevent progression of atherosclerosis and coronary artery disease. Dr. Hamdy was a co-investigator in two landmark studies; the “Diabetes Prevention Program” and “the Look AHEAD Study”. Dr. Hamdy founded the “Weight Achievement and Intensive Treatment-Why WAIT?” program at the Joslin Diabetes Center in 2005, which is currently implemented nationally and internationally. He is also the author of the Haravard Health Publication “The Diabetes Breakthrough”, which outlines his strategy for long-term diabetes weight management. Dr. Hamdy chaired the task force that developed the Joslin Nutrition Guidelines and and cuurently co-chairs the global task force that developed the Transcultural Diabetes Nutrition Alogrithm (tDNA), which leads an effort to improve global health by implementing an effective transcultural lifestyle intervention. Dr. Hamdy won the prestigious 2015 Michaela Modan Award of the American Diabetes Association for his research on long-term diabetes weight management in real-world clinical practice He was nominated by the Harvard Medical School for best mentor award and was given the Compassionate Caregiver Award of the Kenneth Scwartz Center. Dr. Hamdy has more than 150 peer-reviewed original articles, reviews and book chapters. He is on the editorial board of several medical journals including US Eendocrinology, Journal of Nutritional Disorders & Therapy and 2-times section editor of the Current Diabetes Report. He is a member of the editorial review board of many scentific medical journals including JAMA, Diabetes Care, British Medical Journal and Lancet.

Recent & Upcoming Conference Sessions


South Annual Conference

Pharmacological Treatment of Obesity

Sunday, February 11, 2018

10:50 AM - 11:35 AM